Skip to content
pharmaceutical daily

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • News by region
    • East and Central Asia
    • Europe
    • Latin America
    • Middle East and North Africa
    • North America
  • Pharma Business
  • My Pharmaceutical
  • About us
    • Media Kit
    • Privacy Policy
  • Contact

Author: GlobeNewswire

Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy

Pratteln, Switzerland, March 3, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that the last patient has completed the last visit for the first period of the placebo-controlled pivotal VISION-DMD study with vamorolone in patients with Duchenne m…

Published March 3, 2021
Categorized as news Tagged 2428, 2664, 2701, CH0027148649, SWX:SANN

MDxHealth Reports Financial Year 2020 Results and Provides Outlook for 2021

NEWS RELEASE – REGULATED INFORMATION 3 MARCH 2021, 07:00 A.M. CET Conference call with Q&A today at 08:00 CET / 07:00 GMT, details provided below IRVINE, CA, and HERSTAL, BELGIUM – March 3, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercia…

Published March 3, 2021
Categorized as news Tagged BE0003844611, Brussels:MDXH, MyWeb

Idorsia submits European marketing authorisation application for daridorexant for the treatment of adult patients with insomnia

•      The application includes robust data from the Phase 3 registration program, which demonstrated efficacy of daridorexant on objective and subjective sleep parameters, and an improvement in daytime functioning, while maintaining a favorable safety…

Published March 3, 2021
Categorized as news Tagged 99, CH0363463438, SWX:IDIA

ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference

Geneva, Switzerland and Boston, MA – March 3, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that Company Management will p…

Published March 3, 2021
Categorized as news Tagged CH0346177709, Nasdaq:OBSV

In 2020 the “Grindeks” Group has achieved the historically sharpest increase in turnover and profit

In 2020 the “Grindeks” Group has achieved the historically sharpest increase in turnover and profit In 2020 the “Grindeks” Group has achieved the historically sharpest increase in turnover and profit. The consolidated, preliminary financial data…

Published March 3, 2021
Categorized as news Tagged LV0000100659, Riga:GRD1R

ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares

SINGAPORE, March 03, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the pricing of an u…

Published March 3, 2021
Categorized as news Tagged KYG054241099, Nasdaq:ASLN, TAI:6497.TWO, US04522R1014

Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering

WALTHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) — Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of …

Published March 3, 2021
Categorized as news Tagged Nasdaq:MORF, US61775R1059

Rezolute to Participate in Upcoming Investor Conferences in March

REDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), today announced that Nevan Charles Elam, the Company’s CEO and Founder, will be presenting at the following upcoming investor conferences:  Cowen 41st Annual Heal…

Published March 2, 2021
Categorized as news Tagged Nasdaq:RZLT, US76200L3096

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today an…

Published March 2, 2021
Categorized as news Tagged Nasdaq:PACB, US69404D1081

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., March 02, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that on March 1, 2021, the compensation committee of BridgeBio’s boar…

Published March 2, 2021
Categorized as news Tagged Nasdaq:BBIO, US10806X1028

Posts navigation

Page 1 … Page 1,253 Older posts




pharmaceutical daily
Proudly powered by WordPress.